Cargando…

Deep learning improves utility of tau PET in the study of Alzheimer's disease

INTRODUCTION: Positron emission tomography (PET) imaging targeting neurofibrillary tau tangles is increasingly used in the study of Alzheimer's disease (AD), but its utility may be limited by conventional quantitative or qualitative evaluation techniques in earlier disease states. Convolutional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, James, Park, David, Johnson, Aubrey, Feng, Xinyang, Pardo, Michelle, France, Jeanelle, Tomljanovic, Zeljko, Brickman, Adam M., Devanand, Devangere P., Luchsinger, José A., Kreisl, William C., Provenzano, Frank A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Neuroimaging
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719427/ https://www.ncbi.nlm.nih.gov/pubmed/35005197 http://dx.doi.org/10.1002/dad2.12264

Ejemplares similares

Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease
por: Joseph-Mathurin, Nelly, et al.
Publicado: (2018)

Hippocampal subfield imaging and fractional anisotropy show parallel changes in Alzheimer's disease tau progression using simultaneous tau‐PET/MRI at 3T
por: Carlson, Mackenzie L., et al.
Publicado: (2021)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

Head injury is associated with tau deposition on PET in MCI and AD patients
por: Risacher, Shannon L., et al.
Publicado: (2021)

Multimodal neuroimaging study of cerebrovascular disease, amyloid deposition, and neurodegeneration in Alzheimer's disease progression
por: Lao, Patrick J., et al.
Publicado: (2018)

In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease
por: Mak, Elijah, et al.
Publicado: (2018)

Evaluation of a visual interpretation method for tau‐PET with (18)F‐flortaucipir
por: Sonni, Ida, et al.
Publicado: (2020)

Association between neurite metrics and tau/inflammatory pathology in Alzheimer's disease
por: Sone, Daichi, et al.
Publicado: (2020)

Tau PET following acute TBI: Off-target binding to blood products, tauopathy, or both?
por: Butler, Tracy, et al.
Publicado: (2022)

Memory concerns in the early Alzheimer's disease prodrome: Regional association with tau deposition
por: Swinford, Cecily G., et al.
Publicado: (2018)

CSF glucose tracks regional tau progression based on Alzheimer's disease risk factors
por: Pappas, Colleen, et al.
Publicado: (2020)

Untangling tau imaging
por: Villemagne, Victor L., et al.
Publicado: (2016)

The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolism
por: Stage, Eddie, et al.
Publicado: (2016)

Regional tau deposition and subregion atrophy of medial temporal structures in early Alzheimer's disease: A combined positron emission tomography/magnetic resonance imaging study
por: Sone, Daichi, et al.
Publicado: (2017)

Tau pathology in cognitively normal older adults
por: Ziontz, Jacob, et al.
Publicado: (2019)

Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report
por: Mak, Elijah, et al.
Publicado: (2019)

Expanding the phenotypic associations of globular glial tau subtypes
por: Burrell, James R., et al.
Publicado: (2016)

Role of tau deposition in early cognitive decline in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Cerebrovascular stiffness and flow dynamics in the presence of amyloid and tau biomarkers
por: Rivera‐Rivera, Leonardo A., et al.
Publicado: (2021)

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
por: Padilla, Concepcion, et al.
Publicado: (2022)

In vivo network models identify sex differences in the spread of tau pathology across the brain
por: Shokouhi, Sepideh, et al.
Publicado: (2020)

Ictal PET in presurgical workup of refractory extratemporal epilepsy
por: Nooraine, Javeria, et al.
Publicado: (2013)

Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease
por: Keret, Ophir, et al.
Publicado: (2021)

Peri‐arterial pathways for clearance of α‐Synuclein and tau from the brain: Implications for the pathogenesis of dementias and for immunotherapy
por: Nimmo, Jacqui, et al.
Publicado: (2020)

Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography
por: Risacher, Shannon L., et al.
Publicado: (2017)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Microbleeds are associated with depressive symptoms in Alzheimer's disease
por: Leeuwis, Anna E., et al.
Publicado: (2017)

Staging of amyloid β, t-tau, regional atrophy rates, and cognitive change in a nondemented cohort: Results of serial mediation analyses
por: Fletcher, Evan, et al.
Publicado: (2018)

Impaired perfusion and capillary dysfunction in prodromal Alzheimer's disease
por: Nielsen, Rune B., et al.
Publicado: (2020)

Utility of Double Inversion Recovery Sequences in MRI
por: Ryan, Maura E.
Publicado: (2016)

Preoperative [(11)C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas
por: Ninatti, Gaia, et al.
Publicado: (2022)

Degradation in intrinsic connectivity networks across the Alzheimer's disease spectrum
por: Nuttall, Rachel, et al.
Publicado: (2016)

Early affective changes and increased connectivity in preclinical Alzheimer's disease
por: Fredericks, Carolyn A., et al.
Publicado: (2018)

Prediction of Alzheimer's disease pathophysiology based on cortical thickness patterns
por: Hwang, Jihye, et al.
Publicado: (2015)

APOE ε4 and resting‐state functional connectivity in racially/ethnically diverse older adults
por: Turney, Indira C., et al.
Publicado: (2020)

Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer's disease
por: Carlesimo, Giovanni A., et al.
Publicado: (2015)

Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's disease
por: Carlson, Christopher, et al.
Publicado: (2016)

Structural connectivity centrality changes mark the path toward Alzheimer's disease
por: Peraza, Luis R., et al.
Publicado: (2019)

Brain amyloid in preclinical Alzheimer's disease is associated with increased driving risk
por: Ott, Brian R., et al.
Publicado: (2016)

Nonparenchymal fluid is the source of increased mean diffusivity in preclinical Alzheimer's disease
por: Sepehrband, Farshid, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_39ionp2jo65di86fliko0sm21m